Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

When Distress Becomes Somatic: Dementia Family Caregivers' Distress and Genetic Vulnerability to Pain and Sleep Problems.

Wilson SJ, Padin AC, Birmingham DJ, Malarkey WB, Kiecolt-Glaser JK.

Gerontologist. 2018 Nov 23. doi: 10.1093/geront/gny150. [Epub ahead of print]

PMID:
30476041
2.

Cq1 Exon Polymorphisms in Caucasian and African American Systemic Lupus Erythematosus patients.

Irshaid FI, Birmingham DJ.

Pak J Biol Sci. 2018;21(3):119-126. doi: 10.3923/pjbs.2018.119.126.

PMID:
30187721
3.

Biomarkers of lupus nephritis histology and flare: deciphering the relevant amidst the noise.

Birmingham DJ, Merchant M, Waikar SS, Nagaraja H, Klein JB, Rovin BH.

Nephrol Dial Transplant. 2017 Jan 1;32(suppl_1):i71-i79. doi: 10.1093/ndt/gfw300. Review.

4.

The Urine Preservative Acetic Acid Degrades Urine Protein: Implications for Urine Biorepositories and the AASK Cohort Study.

Almaani S, Hebert LA, Rovin BH, Birmingham DJ.

J Am Soc Nephrol. 2017 May;28(5):1394-1398. doi: 10.1681/ASN.2016080886. Epub 2017 Jan 19.

5.

The interleukin-6-hepcidin-hemoglobin circuit in systemic lupus erythematosus flares.

Indrakanti DL, Alvarado A, Zhang X, Birmingham DJ, Hinton A, Rovin BH.

Lupus. 2017 Feb;26(2):200-203. doi: 10.1177/0961203316659153. Epub 2016 Jul 20.

6.

Relationship of Circulating Anti-C3b and Anti-C1q IgG to Lupus Nephritis and Its Flare.

Birmingham DJ, Bitter JE, Ndukwe EG, Dials S, Gullo TR, Conroy S, Nagaraja HN, Rovin BH, Hebert LA.

Clin J Am Soc Nephrol. 2016 Jan 7;11(1):47-53. doi: 10.2215/CJN.03990415. Epub 2015 Dec 23.

7.

The Complement System in Lupus Nephritis.

Birmingham DJ, Hebert LA.

Semin Nephrol. 2015 Sep;35(5):444-54. doi: 10.1016/j.semnephrol.2015.08.006. Review.

PMID:
26573547
8.

Autoantibodies targeting glomerular annexin A2 identify patients with proliferative lupus nephritis.

Caster DJ, Korte EA, Merchant ML, Klein JB, Wilkey DW, Rovin BH, Birmingham DJ, Harley JB, Cobb BL, Namjou B, McLeish KR, Powell DW.

Proteomics Clin Appl. 2015 Dec;9(11-12):1012-20. doi: 10.1002/prca.201400175. Epub 2015 Jun 12.

9.

End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.

Freedman BI, Langefeld CD, Andringa KK, Croker JA, Williams AH, Garner NE, Birmingham DJ, Hebert LA, Hicks PJ, Segal MS, Edberg JC, Brown EE, Alarcón GS, Costenbader KH, Comeau ME, Criswell LA, Harley JB, James JA, Kamen DL, Lim SS, Merrill JT, Sivils KL, Niewold TB, Patel NM, Petri M, Ramsey-Goldman R, Reveille JD, Salmon JE, Tsao BP, Gibson KL, Byers JR, Vinnikova AK, Lea JP, Julian BA, Kimberly RP; Lupus Nephritis–End‐Stage Renal Disease Consortium.

Arthritis Rheumatol. 2014 Feb;66(2):390-6. doi: 10.1002/art.38220.

10.

Spot PC ratio estimates of 24-hour proteinuria are more unreliable in lupus nephritis than in other forms of chronic glomerular disease.

Birmingham DJ, Shidham G, Perna A, Fine DM, Bissell M, Rodby R, Remuzzi G, Petri M, Hebert P, Rovin BH, Hebert LA.

Ann Rheum Dis. 2014 Feb;73(2):475-6. doi: 10.1136/annrheumdis-2013-203790. Epub 2013 Oct 3. No abstract available.

11.

Novel estrogen target gene ZAS3 is overexpressed in systemic lupus erythematosus.

Young NA, Friedman AK, Kaffenberger B, Rajaram MV, Birmingham DJ, Rovin BH, Hebert LA, Schlesinger LS, Wu LC, Jarjour WN.

Mol Immunol. 2013 May;54(1):23-31. doi: 10.1016/j.molimm.2012.10.026. Epub 2012 Nov 22.

12.

FcγRIIb on liver sinusoidal endothelium clears small immune complexes.

Ganesan LP, Kim J, Wu Y, Mohanty S, Phillips GS, Birmingham DJ, Robinson JM, Anderson CL.

J Immunol. 2012 Nov 15;189(10):4981-8. doi: 10.4049/jimmunol.1202017. Epub 2012 Oct 10.

13.

High-sensitivity C-reactive protein, disease activity, and cardiovascular risk factors in systemic lupus erythematosus.

Mok CC, Birmingham DJ, Ho LY, Hebert LA, Rovin BH.

Arthritis Care Res (Hoboken). 2013 Mar;65(3):441-7. doi: 10.1002/acr.21841.

14.

Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans.

Birmingham DJ, Hebert LA, Song H, Noonan WT, Rovin BH, Nagaraja HN, Yu CY.

Lupus. 2012 Jul;21(8):855-64. doi: 10.1177/0961203312439640. Epub 2012 Mar 20.

15.

Characterization of glomerular diseases using proteomic analysis of laser capture microdissected glomeruli.

Satoskar AA, Shapiro JP, Bott CN, Song H, Nadasdy GM, Brodsky SV, Hebert LA, Birmingham DJ, Nadasdy T, Freitas MA, Rovin BH.

Mod Pathol. 2012 May;25(5):709-21. doi: 10.1038/modpathol.2011.205. Epub 2012 Jan 27.

16.

Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q.

Mok CC, Birmingham DJ, Ho LY, Hebert LA, Song H, Rovin BH.

Lupus. 2012 Jan;21(1):36-42. doi: 10.1177/0961203311422094. Epub 2011 Oct 12.

PMID:
21993384
17.

Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis.

Mok CC, Birmingham DJ, Leung HW, Hebert LA, Song H, Rovin BH.

Rheumatology (Oxford). 2012 Apr;51(4):644-52. doi: 10.1093/rheumatology/ker212. Epub 2011 Jun 29. Review.

PMID:
21719424
18.

An approach to validating criteria for proteinuric flare in systemic lupus erythematosus glomerulonephritis.

Ardoin S, Birmingham DJ, Hebert PL, Yu CY, Rovin BH, Hebert LA.

Arthritis Rheum. 2011 Jul;63(7):2031-7. doi: 10.1002/art.30345.

19.

The complex nature of serum C3 and C4 as biomarkers of lupus renal flare.

Birmingham DJ, Irshaid F, Nagaraja HN, Zou X, Tsao BP, Wu H, Yu CY, Hebert LA, Rovin BH.

Lupus. 2010 Oct;19(11):1272-80. doi: 10.1177/0961203310371154. Epub 2010 Jul 6.

20.

Mathematical framework for human SLE Nephritis: disease dynamics and urine biomarkers.

Budu-Grajdeanu P, Schugart RC, Friedman A, Birmingham DJ, Rovin BH.

Theor Biol Med Model. 2010 May 17;7:14. doi: 10.1186/1742-4682-7-14.

21.

Can we personalize treatment for kidney diseases?

Rovin BH, McKinley AM, Birmingham DJ.

Clin J Am Soc Nephrol. 2009 Oct;4(10):1670-6. doi: 10.2215/CJN.04140609. Epub 2009 Sep 17. Review.

22.

Expression of the decay-accelerating factor (CD55) in renal transplants--a possible prediction marker of allograft survival.

Brodsky SV, Nadasdy GM, Pelletier R, Satoskar A, Birmingham DJ, Hadley GA, Obeidat K, Nadasdy T.

Transplantation. 2009 Aug 27;88(4):457-64. doi: 10.1097/TP.0b013e3181b0517d.

PMID:
19696627
23.

Random spot urine protein/creatinine ratio is unreliable for estimating 24-hour proteinuria in individual systemic lupus erythematosus nephritis patients.

Hebert LA, Birmingham DJ, Shidham G, Rovin B, Nagaraja HN, Yu CY.

Nephron Clin Pract. 2009;113(3):c177-82. doi: 10.1159/000232599. Epub 2009 Aug 12.

24.

D-dimer level and the risk for thrombosis in systemic lupus erythematosus.

Wu H, Birmingham DJ, Rovin B, Hackshaw KV, Haddad N, Haden D, Yu CY, Hebert LA.

Clin J Am Soc Nephrol. 2008 Nov;3(6):1628-36. doi: 10.2215/CJN.01480308.

25.

Biomarkers of lupus nephritis determined by serial urine proteomics.

Zhang X, Jin M, Wu H, Nadasdy T, Nadasdy G, Harris N, Green-Church K, Nagaraja H, Birmingham DJ, Yu CY, Hebert LA, Rovin BH.

Kidney Int. 2008 Sep;74(6):799-807. doi: 10.1038/ki.2008.316. Epub 2008 Jul 2.

26.

Relationship between albuminuria and total proteinuria in systemic lupus erythematosus nephritis: diagnostic and therapeutic implications.

Birmingham DJ, Rovin BH, Shidham G, Bissell M, Nagaraja HN, Hebert LA.

Clin J Am Soc Nephrol. 2008 Jul;3(4):1028-33. doi: 10.2215/CJN.04761107. Epub 2008 May 1.

27.

Phenotypes, genotypes and disease susceptibility associated with gene copy number variations: complement C4 CNVs in European American healthy subjects and those with systemic lupus erythematosus.

Wu YL, Yang Y, Chung EK, Zhou B, Kitzmiller KJ, Savelli SL, Nagaraja HN, Birmingham DJ, Tsao BP, Rovin BH, Hebert LA, Yu CY.

Cytogenet Genome Res. 2008;123(1-4):131-41. doi: 10.1159/000184700. Epub 2009 Mar 11. Review.

28.

Biomarker discovery in human SLE nephritis.

Rovin BH, Birmingham DJ, Nagaraja HN, Yu CY, Hebert LA.

Bull NYU Hosp Jt Dis. 2007;65(3):187-93. Review.

30.

Spot urine protein/creatinine ratios are unreliable estimates of 24 h proteinuria in most systemic lupus erythematosus nephritis flares.

Birmingham DJ, Rovin BH, Shidham G, Nagaraja HN, Zou X, Bissell M, Yu CY, Hebert LA.

Kidney Int. 2007 Oct;72(7):865-70. Epub 2007 Jul 25.

31.

Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans.

Yang Y, Chung EK, Wu YL, Savelli SL, Nagaraja HN, Zhou B, Hebert M, Jones KN, Shu Y, Kitzmiller K, Blanchong CA, McBride KL, Higgins GC, Rennebohm RM, Rice RR, Hackshaw KV, Roubey RA, Grossman JM, Tsao BP, Birmingham DJ, Rovin BH, Hebert LA, Yu CY.

Am J Hum Genet. 2007 Jun;80(6):1037-54. Epub 2007 Apr 26.

32.

A polymorphism in the type one complement receptor (CR1) involves an additional cysteine within the C3b/C4b binding domain that inhibits ligand binding.

Birmingham DJ, Irshaid F, Gavit KF, Nagaraja HN, Yu CY, Rovin BH, Hebert LA.

Mol Immunol. 2007 Jul;44(14):3510-6. Epub 2007 Apr 30.

33.

A dinucleotide deletion in CD24 confers protection against autoimmune diseases.

Wang L, Lin S, Rammohan KW, Liu Z, Liu JQ, Liu RH, Guinther N, Lima J, Zhou Q, Wang T, Zheng X, Birmingham DJ, Rovin BH, Hebert LA, Wu Y, Lynn DJ, Cooke G, Yu CY, Zheng P, Liu Y.

PLoS Genet. 2007 Apr 6;3(4):e49. Epub 2007 Feb 21.

34.

Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus.

Wu H, Boackle SA, Hanvivadhanakul P, Ulgiati D, Grossman JM, Lee Y, Shen N, Abraham LJ, Mercer TR, Park E, Hebert LA, Rovin BH, Birmingham DJ, Chang DM, Chen CJ, McCurdy D, Badsha HM, Thong BY, Chng HH, Arnett FC, Wallace DJ, Yu CY, Hahn BH, Cantor RM, Tsao BP.

Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):3961-6. Epub 2007 Feb 22.

35.

Fluctuation in self-perceived stress and increased risk of flare in patients with lupus nephritis carrying the serotonin receptor 1A -1019 G allele.

Birmingham DJ, Nagaraja HN, Rovin BH, Spetie L, Zhao Y, Li X, Hackshaw KV, Yu CY, Malarkey WB, Hebert LA.

Arthritis Rheum. 2006 Oct;54(10):3291-9.

36.

Three distinct profiles of serum complement C4 proteins in pediatric systemic lupus erythematosus (SLE) patients: tight associations of complement C4 and C3 protein levels in SLE but not in healthy subjects.

Wu YL, Higgins GC, Rennebohm RM, Chung EK, Yang Y, Zhou B, Nagaraja HN, Birmingham DJ, Rovin BH, Hebert LA, Yu CY.

Adv Exp Med Biol. 2006;586:227-47.

PMID:
16893076
37.

Consumption of erythrocyte CR1 (CD35) is associated with protection against systemic lupus erythematosus renal flare.

Birmingham DJ, Gavit KF, McCarty SM, Yu CY, Rovin BH, Nagaraja HN, Hebert LA.

Clin Exp Immunol. 2006 Feb;143(2):274-80.

38.

Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosus.

Rovin BH, Song H, Hebert LA, Nadasdy T, Nadasdy G, Birmingham DJ, Yung Yu C, Nagaraja HN.

Kidney Int. 2005 Oct;68(4):1825-33.

39.

Association analysis of the R620W polymorphism of protein tyrosine phosphatase PTPN22 in systemic lupus erythematosus families: increased T allele frequency in systemic lupus erythematosus patients with autoimmune thyroid disease.

Wu H, Cantor RM, Graham DS, Lingren CM, Farwell L, Jager PL, Bottini N, Grossman JM, Wallace DJ, Hahn BH, Julkunen H, Hebert LA, Rovin BH, Birmingham DJ, Rioux JD, Yu CY, Kere J, Vyse TJ, Tsao BP.

Arthritis Rheum. 2005 Aug;52(8):2396-402.

40.

Clinical significance of fever in the systemic lupus erythematosus patient receiving steroid therapy.

Rovin BH, Tang Y, Sun J, Nagaraja HN, Hackshaw KV, Gray L, Rice R, Birmingham DJ, Yu CY, Spetie DN, Aziz A, Hebert LA.

Kidney Int. 2005 Aug;68(2):747-59.

41.

Urine chemokines as biomarkers of human systemic lupus erythematosus activity.

Rovin BH, Song H, Birmingham DJ, Hebert LA, Yu CY, Nagaraja HN.

J Am Soc Nephrol. 2005 Feb;16(2):467-73. Epub 2004 Dec 15.

42.

Identification of the Kna/Knb polymorphism and a method for Knops genotyping.

Moulds JM, Thomas BJ, Doumbo O, Diallo DA, Lyke KE, Plowe CV, Rowe JA, Birmingham DJ.

Transfusion. 2004 Feb;44(2):164-9. Erratum in: Transfusion. 2004 May;44(5):799-800.

43.

The intricate role of complement component C4 in human systemic lupus erythematosus.

Yang Y, Chung EK, Zhou B, Lhotta K, Hebert LA, Birmingham DJ, Rovin BH, Yu CY.

Curr Dir Autoimmun. 2004;7:98-132. Review.

PMID:
14719377
44.

A human CR1-like transcript containing sequence for a binding protein for iC4 is expressed in hematopoietic and fetal lymphoid tissue.

Logar CM, Chen W, Schmitt H, Yu CY, Birmingham DJ.

Mol Immunol. 2004 Jan;40(11):831-40.

PMID:
14687939
45.

A CR1 polymorphism associated with constitutive erythrocyte CR1 levels affects binding to C4b but not C3b.

Birmingham DJ, Chen W, Liang G, Schmitt HC, Gavit K, Nagaraja HN.

Immunology. 2003 Apr;108(4):531-8.

46.

Of mice and men: the relevance of the mouse to the study of human SLE.

Birmingham DJ, Rovin BH, Yu CY, Hebert LA.

Immunol Res. 2001;24(2):211-24. Review.

PMID:
11594458
47.

CR1 and CR1-like: the primate immune adherence receptors.

Birmingham DJ, Hebert LA.

Immunol Rev. 2001 Apr;180:100-11. Review.

PMID:
11414352
48.

Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1.

Moulds JM, Zimmerman PA, Doumbo OK, Kassambara L, Sagara I, Diallo DA, Atkinson JP, Krych-Goldberg M, Hauhart RE, Hourcade DE, McNamara DT, Birmingham DJ, Rowe JA, Moulds JJ, Miller LH.

Blood. 2001 May 1;97(9):2879-85.

49.

The chimpanzee and cynomolgus monkey erythrocyte immune adherence receptors are encoded by CR1-like genes.

Chen W, Logar CM, Shen XP, Birmingham DJ.

Immunogenetics. 2000 Nov;52(1-2):46-52.

PMID:
11132156
50.

Effects of immune complex formation and complement activation on circulating platelets in the primate.

Birmingham DJ, Hebert LA, Shen XP, Higgins P, Yeh CG, Creasey AA.

Clin Immunol. 1999 Apr;91(1):99-105.

PMID:
10219260

Supplemental Content

Loading ...
Support Center